When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease
Gynecologic and Obstetric Investigation · 2024
DOI: 10.1159/000531218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2024. Verfasst von Lesley McMahon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School, Dundee, UK. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase Inhibitor p57, Gestational Trophoblastic Disease, Hydatidiform Mole, Uterine Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
Gestational trophoblastic disease comprises hydatidiform moles and a rare group of malignancies that derive from trophoblasts. Although there are typical morphological features that may distinguish hydatidiform moles from non-molar products of conception, such features are not always present, especially at early stages of pregnancy. Furthermore, mosaic/chimeric pregnancies and twin pregnancies make pathological diagnosis challenging while trophoblastic tumours can also pose diagnostic problems in terms of their gestational or non-gestational origin.
Objectives
The aim of this study was to show that ancillary genetic testing can be used to aid diagnosis and clinical management of GTD.
Methods
Each author identified cases where genetic testing, including short tandem repeat (STR) genotyping, ploidy analysis, next-generation sequencing, and immunostaining for p57, the product of the imprinted gene CDKN1C, facilitated accurate diagnosis and improved patient management. Representative cases were chosen to illustrate the value of ancillary genetic testing in different scenarios. Outcome: Genetic analysis of placental tissue can aid in determining the risk of developing gestational trophoblastic neoplasia, facilitating discrimination between low risk triploid (partial) and high risk androgenetic (complete) moles, discriminating between a hydatidiform mole twinned with a normal conceptus and a triploid conception and identification of androgenetic/biparental diploid mosaicism/chimerism. STR genotyping of placental tissue and targeted gene sequencing of patients can identify women with an inherited predisposition to recurrent molar pregnancies. Genotyping can distinguish gestational from non-gestational trophoblastic tumours using tissue or circulating tumour DNA and can also identify the causative pregnancy which is the key prognostic factor for placental site and epithelioid trophoblastic tumours. Conclusions and Outlook: STR genotyping and p57 immunostaining have been invaluable to the management of gestational trophoblastic disease in many situations. The use of next-generation sequencing and of liquid biopsies is opening up new pathways for GTD diagnostics. Development of these techniques has the potential to identify novel biomarkers of GTD and further refine diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School, Dundee, UK.
- Trophoblastic Tumour Screening and Treatment Centre, Imperial College NHS Trust, Charing Cross Hospital, London, UK, Geoffrey.maher@imperial.ac.uk.
- Pregnancy Loss Research Group, Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland.
- Department of Clinical Biochemistry, Cork University Hospital, Cork, Ireland.
- Department of Gynaecology and Obstetrics, Randers Regional Hospital, Randers, Denmark.
- Trophoblastic Tumour Screening and Treatment Centre, Imperial College NHS Trust, Charing Cross Hospital, London, UK.
Zitieren
APA
McMahon, L., Maher, G. J., Joyce, C., Niemann, I., Fisher, R., & Sunde, L. (2024). When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000531218
Vancouver
McMahon L, Maher GJ, Joyce C, Niemann I, Fisher R, Sunde L. When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease. Gynecologic and Obstetric Investigation. 2024. doi:10.1159/000531218
BibTeX
@article{McMahon2024,
author = {McMahon, Lesley and Maher, Geoffrey J and Joyce, Caroline and Niemann, Isa and Fisher, Rosemary and Sunde, Lone},
title = {When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease},
journal = {Gynecologic and Obstetric Investigation},
year = {2024},
doi = {10.1159/000531218}
}
EUVIMED